Apellis Pharmaceuticals, Inc. (26) | Uncategorized (9)

Recent Contracts

Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on February 28, 2022)
Offer Letter, dated as of April 20, 2020, by and between the Registrant and Nur Nicholson (Filed With SEC on February 28, 2022)
Offer Letter, dated as of November 16, 2018, by and between the Registrant and Adam Townsend (Filed With SEC on February 28, 2022)
Open Market Sale AgreementSM, dated as of January 20, 2022, by and between Apellis Pharmaceuticals, Inc. and Jefferies LLC (Filed With SEC on January 20, 2022)
Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on February 25, 2021)
Form of Capped Call Transaction Confirmation (Filed With SEC on May 7, 2020)
Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on February 27, 2020)
Form of Capped Call Transaction Confirmation (Filed With SEC on September 16, 2019)
Offer Letter, dated as of April 13, 2018, by and between the Registrant and Lukas Scheibler (Filed With SEC on May 7, 2019)